Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia

BACKGROUND Actigraphy is a quantitative method for measurement of motor activity. In the present study we used actigraphy to examine diurnal variations in locomotor activity of schizophrenic patients with neuroleptic-induced akathisia (NIA). METHOD Thirty-two schizophrenic patients, 16 with NIA and 16 without (DSM-IV criteria) underwent 24-h actigraphic monitoring. Clinical assessments of NIA were conducted with Barnes Akathisia Scale (BAS) at 08:00, 12:00, 16:00 and 20:00. Sleep parameters (duration, latency, continuity and efficacy) were assessed by actigraphy. Sleep quality was evaluated by a self-rated sleep questionnaire. RESULTS NIA patients demonstrated persistent higher daytime motor activity from 11:30 to 14:15 and from 18:00 to 21:00 than controls. There were no differences between the groups in nighttime motor activity, confirming clinical observations that NIA tends to disappear during sleep. Subject's sleep assessments were similar in the two groups. CONCLUSIONS Actigraphy seems to be a reliable, non-invasive, method of measuring motor activity in patients with NIA. Its sensitivity and specificity as an objective quantitative diagnostic instrument in patients with NIA merits further investigation.

[1]  P. Sachdev Akathisia and Restless Legs , 1995 .

[2]  H. Lauerma,et al.  Mianserin and restless legs. , 1997, International clinical psychopharmacology.

[3]  Abraham Weizman,et al.  Serotonergic agents in the treatment of acute neuroleptic‐induced akathisia: open‐label study of buspirone and mianserin , 1997, International clinical psychopharmacology.

[4]  S. Chokroverty,et al.  A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome. , 1991, Sleep.

[5]  C. Fuchs,et al.  Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin , 1999, British Journal of Psychiatry.

[6]  P. Weiden,et al.  Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. , 1987, American Journal of Psychiatry.

[7]  A. Elizur,et al.  Akathisia and pseudoakathisia: clinical observations and accelerometric recordings. , 1994, The Journal of clinical psychiatry.

[8]  Martin H. Teicher,et al.  Quantitative assessment of psychomotor activity in patients with neuroleptic-induced akathisia , 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  G. Simpson,et al.  Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. , 1990, Archives of general psychiatry.

[10]  Zung Ww Effect of clorazepate on depressed mood in anxious patients. , 1987 .

[11]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[12]  M. Egan,et al.  Diurnal variation in tardive dyskinesia , 1995, Psychiatry Research.

[13]  M. Kryger,et al.  Principles and Practice of Sleep Medicine , 1989 .

[14]  Martin H. Teicher Actigraphy and Motion Analysis: New Tools for Psychiatry , 1995, Harvard review of psychiatry.

[15]  T. Putten Why do schizophrenic patients refuse to take their drugs , 1974 .

[16]  M. Mazurek,et al.  Circadian pattern of acute, neuroleptic-induced dystonic reactions. , 1996, The American journal of psychiatry.

[17]  P. Keck,et al.  Polysomnographic Characteristics of Neuroleptic‐Induced Akathisia , 1991, Clinical neuropharmacology.

[18]  J. Kane,et al.  Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin. , 1990, Psychopharmacology bulletin.

[19]  T. Barnes A Rating Scale for Drug-Induced Akathisia , 1989, British Journal of Psychiatry.

[20]  Martin H. Teicher,et al.  Circadian locomotor activity rhythms in Alzheimer's disease. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[21]  P. Lavie,et al.  Actigraphic measurements of sleep in rheumatoid arthritis: comparison of patients with low back pain and healthy controls. , 1992, The Journal of rheumatology.